Innospec declares $0.87 semi-annual dividend; posts quarterly results
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Innospec Inc. reported that it issued a press release announcing its financial results for the fiscal quarter ended September 30, 2025. The company also declared a semi-annual dividend of $0.87 per share on its common stock.
The dividend will be paid on November 26, 2025 to shareholders of record as of November 18, 2025. The press release was furnished as Exhibit 99.1, providing details on the quarter’s performance.
Positive
- None.
Negative
- None.
8-K Event Classification
3 items: 2.02, 7.01, 9.01
3 items
Item 2.02
Results of Operations and Financial Condition
Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
FAQ
What did Innospec (IOSP) announce in this filing?
Innospec announced a press release with results for the fiscal quarter ended September 30, 2025, and declared a semi-annual dividend of $0.87 per share.
What is the dividend amount declared by Innospec (IOSP)?
The Board declared a semi-annual dividend of $0.87 per share on common stock.
When is the record date for Innospec’s $0.87 dividend?
Shareholders of record on November 18, 2025 will be eligible for the dividend.
When will Innospec pay the declared dividend?
The dividend will be paid on November 26, 2025.
Which period do the reported results cover for Innospec (IOSP)?
They cover the fiscal quarter ended September 30, 2025.
Where can investors find the detailed results?
Details are in the press release furnished as Exhibit 99.1 to the filing.
What is Innospec’s trading symbol and exchange?
Innospec’s common stock trades on NASDAQ under the symbol IOSP.